[go: up one dir, main page]

TN2018000135A1 - Extraction and exploitation of beta keratin, beta keratin and its derivatives. - Google Patents

Extraction and exploitation of beta keratin, beta keratin and its derivatives.

Info

Publication number
TN2018000135A1
TN2018000135A1 TNP/2018/000135A TN2018000135A TN2018000135A1 TN 2018000135 A1 TN2018000135 A1 TN 2018000135A1 TN 2018000135 A TN2018000135 A TN 2018000135A TN 2018000135 A1 TN2018000135 A1 TN 2018000135A1
Authority
TN
Tunisia
Prior art keywords
keratin
extraction
beta keratin
beta
protein
Prior art date
Application number
TNP/2018/000135A
Other languages
French (fr)
Inventor
Ghidhaoui Abir
Original Assignee
Ghidhaoui Abir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ghidhaoui Abir filed Critical Ghidhaoui Abir
Priority to TNP/2018/000135A priority Critical patent/TN2018000135A1/en
Priority to PCT/TN2019/000004 priority patent/WO2019209188A1/en
Publication of TN2018000135A1 publication Critical patent/TN2018000135A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/002Preparations for repairing the hair, e.g. hair cure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/006Antidandruff preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/12Preparations containing hair conditioners
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30Characterized by the absence of a particular group of ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)

Abstract

L'extraction innovante et le nouveau solvant inventé ont permis l'extraction de la protéine de la kératine béta en toute sa conformité et sa stabilité. Cette protéine est favorisée par rapport la kératine alpha, pour l'utilisation humaine, car elle ne nécessite pas l'addition des produits chimique et des fixateurs pour qu'elle puisse donner un effet. La kératine béta est destinée pour l'industrie pharmaceutique, parapharmaceutique et cosmétique. La technique et la protéine sont utilisées par le laboratoire d'industrie pharmaceutique et parapharmaceutique, en exclusivité, Aujourd'hui.The innovative extraction and the new invented solvent allowed the extraction of the protein from beta keratin in all its conformity and stability. This protein is favored over alpha keratin, for human use, as it does not require the addition of chemicals and fixatives for it to give an effect. Beta keratin is intended for the pharmaceutical, parapharmaceutical and cosmetic industries. The technique and the protein are used by the pharmaceutical and parapharmaceutical industry laboratory, exclusively, Today.

TNP/2018/000135A 2018-04-24 2018-04-24 Extraction and exploitation of beta keratin, beta keratin and its derivatives. TN2018000135A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TNP/2018/000135A TN2018000135A1 (en) 2018-04-24 2018-04-24 Extraction and exploitation of beta keratin, beta keratin and its derivatives.
PCT/TN2019/000004 WO2019209188A1 (en) 2018-04-24 2019-02-19 Extraction and use of beta-keratin, beta-keratin and the derivatives thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TNP/2018/000135A TN2018000135A1 (en) 2018-04-24 2018-04-24 Extraction and exploitation of beta keratin, beta keratin and its derivatives.

Publications (1)

Publication Number Publication Date
TN2018000135A1 true TN2018000135A1 (en) 2019-10-04

Family

ID=66530404

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP/2018/000135A TN2018000135A1 (en) 2018-04-24 2018-04-24 Extraction and exploitation of beta keratin, beta keratin and its derivatives.

Country Status (2)

Country Link
TN (1) TN2018000135A1 (en)
WO (1) WO2019209188A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4532528A1 (en) * 2022-05-27 2025-04-09 Stimlabs LLC Keratin protein extracts, compositions, methods and uses thereof
FR3161359A1 (en) 2024-04-19 2025-10-24 Hkvor PROCESS FOR EXTRACTION OF HUMAN KERATIN FROM HAIR

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2487197A2 (en) * 1979-05-11 1982-01-29 Thomas Andre Extraction of glyco:proteins and muco:polysaccharide(s) - by macerating animal tissue in a slightly alkaline buffer
MXPA05005597A (en) * 2002-11-28 2005-07-26 Keratec Ltd Personal care formulations containing keratin.
EP3412683B1 (en) * 2011-08-17 2022-02-09 KeraNetics, Inc. Methods for extracting keratin proteins

Also Published As

Publication number Publication date
WO2019209188A9 (en) 2019-12-05
WO2019209188A1 (en) 2019-10-31

Similar Documents

Publication Publication Date Title
CO2020005645A2 (en) Trispecific proteins and methods of use
EA202091711A1 (en) HETEROCYCLYLAMINE-SUBSTITUTED TRIAZOLES AS MODULATORS OF RHO-ASSOCIATED PROTEINKINASE
BR112018013827A2 (en) 5'-nucleotidase modulators, ecto and use thereof
MX2021007570A (en) ARNI AGENT COMPOSITIONS OF AMYLOID PRECURSOR PROTEIN (APP) AND METHODS OF USE THEREOF.
EA201990221A1 (en) 1,3-DIHYDROXIPHENYL DERIVATIVES APPLICABLE AS IMMUNOMODULATORS
BR112019023856A2 (en) triespecific proteins targeting msln and methods of use
CL2018003178A1 (en) Pharmaceutical composition
TN2018000135A1 (en) Extraction and exploitation of beta keratin, beta keratin and its derivatives.
EA202091318A1 (en) A PREPARATION CONTAINING GROUP B ADENOVIRUS
EA201890198A1 (en) NEW PROTEINS SPECIFIC FOR THE LAG-3
CL2019003404A1 (en) Isolated tumor associated peptide (tumap); nucleic acid; expression vector; recombinant host cell comprising the peptide; method of producing the peptide; use to prepare a rare useful drug to treat cancer; pharmaceutical kit. (divisional application 201702407)
EA201991951A1 (en) LOW-VISCOUS HIGH-CONCENTRATED COMPOSITIONS BASED ON EVOLOCUMABA AND METHODS FOR PRODUCING THEM
EP4553065A3 (en) Novel compounds for treating mitochondrial disease
MX2020010178A (en) HAIR STYLING COMPOSITIONS COMPRISING POLYGALACTOMANS AND A METHOD FOR USE THEREOF.
MA46548A (en) FSH FOR INFERTILITY TREATMENT
EA202193245A1 (en) LIQUID COMPOSITION OF BOTULINIC TOXIN FOR THE TREATMENT OF EYEBROW WRINKLES AND LATERAL PERIORBITAL WRINKLES FROM MODERATE TO STRONGLY PROGRESSED
EP3957314A4 (en) USE OF EXTRACT FROM RABBIT SKIN INFLATED BY VACCINE VIRUS IN THE TREATMENT OF DAMAGE TO THE HEMATOPOIETIC SYSTEM
EA202192008A1 (en) LILRB3-BINDING MOLECULES AND VARIANTS OF THEIR APPLICATION
BR112023022367A2 (en) ANTI-TIGIT ANTIBODIES AND METHODS OF USE THEREOF
CO2018011420A2 (en) Liquid phosphaplatin formulations
EP4157320A4 (en) TYPE 2 CYTOKINES AS PREDICTORS OF DISEASE SEVERITY AND/OR THERAPEUTIC TARGETS FOR COVID-19
MY209375A (en) Carbamoyl cyclohexane derivatives for treating autism spectrum disorder
EA202190766A1 (en) IMMUNOMODULATORS, THEIR COMPOSITIONS AND METHODS OF APPLICATION
MX2023004807A (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF CELIACIA.
EA202190014A1 (en) COMPOSITION CONTAINING GLYCIRRISIN AND ITS COSMETIC PRODUCT AND PHARMACEUTICAL APPLICATIONS